Frequencies of KIT and GNAQ mutations in acral melanoma

Journal of Cutaneous Pathology

Volumn 41, Issue 11, 2014, Pages 893-894

  Puntervoll, Hanne Eknes ^a   Molven, Anders ^a,b   Akslen, Lars Andreas ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

cancer; malignant melanoma; molecular pathology

Indexed keywords

GNAQ PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; NRAS PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR;

BLACK PERSON; CAUCASIAN; ETHNOLOGY; FEMALE; FOOT; GENETICS; HAND; HUMAN; MALE; MELANOMA; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; SKIN TUMOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOOT; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEIN ALPHA SUBUNITS; HAND; HUMANS; MALE; MELANOMA; MEMBRANE PROTEINS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS;

EID: 84913594117     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12382     Document Type: Letter

References (5)

1. Curtin JA, Busam K, Pinkel D, Bastian BC,. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340.
2. Akslen LA, Puntervoll H, Bachmann IM, et al. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma Res 2008; 18: 29.
3. Carvajal RD, Antonescu CR, Wolchok JD, et al. KIT as a therapeutic target in metastatic melanoma. JAMA 2011; 305: 2327.
4. National Center for Biotechnology Information, Bethesda, MD, USA. URL http://www.ncbi.nlm.nih.gov/ [accessed on June 2014].
5. Jain N, Curran E, Iyengar NM, et al. Phase II study of the oral MEK inhibitor Selumetinib in advanced acute myelogenous leukemia: A University of Chicago Phase II Consortium Trial. Clin Cancer Res 2014; 20: 490.